Global, regional and national burdens of reproduction-related congenital birth defects, 1990-2019

Front Public Health. 2024 Feb 26:12:1328282. doi: 10.3389/fpubh.2024.1328282. eCollection 2024.

Abstract

Background: Reproduction-related congenital birth defects (RCBDs), including Klinefelter syndrome (KS), Turner syndrome (TS), and urogenital congenital anomalies (UCA), can lead to severe physical and psychosocial disorders. The global impact of RCBDs on children and adults is unknown, which limits high-quality development of populations and increases in life expectancy per capita.

Methods: Annual incidence rates, prevalence rates (PR), and disability-adjusted life year (DALY) rates were collected for KS, TS, and UCA for 204 countries and territories, including at birth, for children younger than 1 year, and age-standardized (AS) for all ages. Linear regression was used to calculate their estimated annual percentage changes (EAPCs). Finally, the relationships between EAPCs of each indicator and sociodemographic index (SDI) was investigated using Pearson correlation analysis.

Results: Globally, the age-standardized prevalence rate (ASPR) trend is decreasing in KS and TS and increasing in UCA. The DALY rates for children younger than 1 year were on a downward trend in KS and UCA, while they were still rising for TS. The AS-DALY rates were all on a downward trend in KS, TS, and UCA. The DALY rates of KS, TS and UCA were found higher in high-income countries in North America. In addition, the burdens of TS and UCA went down with increasing SDI, whereas the burden of KS increased with increasing SDI.

Conclusion: The global burdens of RCBDs have decreased since 1990. This finding can help policymakers implement cost-effective interventions to reduce the burdens of RCBDs.

Keywords: Klinefelter syndrome; Turner syndrome; congenital birth defects; global burden of disease; urogenital congenital anomalies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Child
  • Global Burden of Disease*
  • Global Health*
  • Humans
  • Infant, Newborn
  • Life Expectancy
  • Prevalence
  • Reproduction

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. There were no funds for this study, except for the GBD study which was partially funded by the Bill and Melinda Gates Foundation.